Moleculin Regains Compliance with NASDAQ Listing Requirements
HOUSTON, TX--(Marketwired - July 12, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based …